HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pierfrancesco Tassone Selected Research

SANT-7

6/2005Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu In vivo model of human multiple myeloma.
10/2002The IL-6 receptor super-antagonist Sant7 enhances antiproliferative and apoptotic effects induced by dexamethasone and zoledronic acid on multiple myeloma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pierfrancesco Tassone Research Topics

Disease

100Neoplasms (Cancer)
06/2022 - 04/2002
75Multiple Myeloma
10/2021 - 10/2002
11Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2021 - 05/2010
9Hematologic Neoplasms (Hematological Malignancy)
03/2020 - 12/2004
9Colorectal Neoplasms (Colorectal Cancer)
01/2019 - 11/2011
8Breast Neoplasms (Breast Cancer)
01/2019 - 05/2005
6Ovarian Neoplasms (Ovarian Cancer)
05/2022 - 10/2009
6Colonic Neoplasms (Colon Cancer)
06/2012 - 04/2003
5Melanoma (Melanoma, Malignant)
01/2022 - 01/2020
5Neoplasm Metastasis (Metastasis)
01/2018 - 12/2011
4Genomic Instability
01/2021 - 01/2019
4Carcinoma (Carcinomatosis)
02/2020 - 07/2002
4Bone Diseases (Bone Disease)
11/2017 - 07/2009
3Inflammation (Inflammations)
01/2020 - 06/2005
3Ovarian Epithelial Carcinoma
11/2018 - 05/2016
3Disease Progression
11/2017 - 08/2014
3Pancreatic Neoplasms (Pancreatic Cancer)
03/2016 - 10/2009
3Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
07/2009 - 07/2005
2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
06/2022 - 01/2021
2Hypoxia (Hypoxemia)
12/2021 - 05/2014
2Rare Diseases (Rare Disease)
01/2021 - 03/2020
2Paraproteinemias (Monoclonal Gammopathy)
01/2021 - 01/2020
2Lung Neoplasms (Lung Cancer)
11/2020 - 01/2019
2Lymphoma (Lymphomas)
10/2020 - 07/2006
2Pneumonia (Pneumonitis)
01/2020 - 05/2010
2Prostatic Neoplasms (Prostate Cancer)
11/2016 - 12/2011
2Fever (Fevers)
04/2016 - 09/2015
2Arthralgia (Joint Pain)
04/2016 - 09/2015
2Rhinitis
04/2016 - 09/2015
2Stomach Neoplasms (Stomach Cancer)
03/2016 - 01/2015
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2015 - 09/2013
2Chromosome Aberrations (Chromosome Abnormalities)
08/2014 - 06/2013

Drug/Important Bio-Agent (IBA)

36MicroRNAs (MicroRNA)IBA
03/2022 - 09/2012
19Biological ProductsIBA
01/2021 - 04/2002
14Biomarkers (Surrogate Marker)IBA
03/2022 - 10/2007
13Pharmaceutical PreparationsIBA
10/2020 - 07/2004
12Monoclonal AntibodiesIBA
03/2021 - 07/2006
10Immune Checkpoint InhibitorsIBA
01/2022 - 11/2016
8AntigensIBA
06/2022 - 04/2002
8Bortezomib (Velcade)FDA Link
02/2019 - 07/2005
8GemcitabineFDA Link
04/2016 - 07/2008
7Proteins (Proteins, Gene)FDA Link
12/2021 - 04/2003
7Long Noncoding RNAIBA
01/2021 - 01/2018
6PlatinumIBA
05/2022 - 04/2009
6DNA (Deoxyribonucleic Acid)IBA
01/2022 - 10/2012
6Dexamethasone (Maxidex)FDA LinkGeneric
10/2018 - 10/2002
6Interleukin-6 (Interleukin 6)IBA
04/2013 - 10/2002
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2021 - 08/2008
5locked nucleic acidIBA
01/2021 - 01/2014
5LNA-i-miR-221IBA
09/2020 - 01/2014
5EpitopesIBA
01/2020 - 05/2011
5mouse MIRN29 microRNAIBA
12/2017 - 10/2012
5Bevacizumab (Avastin)FDA Link
09/2017 - 05/2010
4Messenger RNA (mRNA)IBA
01/2021 - 01/2005
4Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2021 - 12/2011
4Untranslated RNA (Noncoding RNA)IBA
01/2020 - 06/2013
4Peptides (Polypeptides)IBA
01/2020 - 09/2015
4EnzymesIBA
01/2020 - 09/2015
4Cisplatin (Platino)FDA LinkGeneric
09/2017 - 04/2009
4Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
09/2015 - 07/2008
4Irinotecan (Camptosar)FDA LinkGeneric
06/2012 - 12/2004
4Zoledronic Acid (Zometa)FDA Link
12/2011 - 10/2002
4Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
10/2007 - 10/2002
3CytokinesIBA
06/2022 - 09/2007
3Carboplatin (JM8)FDA LinkGeneric
05/2022 - 12/2016
3AntibodiesIBA
03/2021 - 04/2016
3NivolumabIBA
02/2020 - 07/2019
3tetraphenylporphine sulfonate (TPPS)IBA
04/2018 - 09/2015
3Thymidylate SynthaseIBA
04/2018 - 09/2015
3Etoposide (VP 16)FDA LinkGeneric
09/2017 - 05/2010
3Oxaliplatin (Eloxatin)FDA LinkGeneric
04/2016 - 05/2010
3Interleukin-2 (IL2)IBA
04/2016 - 01/2014
3LipidsIBA
06/2014 - 01/2014
3Fluorouracil (Carac)FDA LinkGeneric
01/2014 - 05/2010
3ParaproteinsIBA
08/2005 - 07/2004
2Glycoproteins (Glycoprotein)IBA
06/2022 - 05/2011
2IntegrinsIBA
01/2022 - 06/2011
2Lenalidomide (CC 5013)FDA Link
08/2021 - 12/2009
2PolyphenolsIBA
01/2020 - 07/2019
2Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
08/2019 - 12/2004
2Proteasome Endopeptidase Complex (Proteasome)IBA
02/2019 - 01/2018
2Glucuronosyltransferase (UDP Glucuronosyltransferase)IBA
01/2019 - 11/2011
2Doxorubicin (Adriamycin)FDA LinkGeneric
10/2018 - 07/2005
2VaccinesIBA
04/2018 - 09/2015
2Tumor Biomarkers (Tumor Markers)IBA
11/2017 - 01/2014
2Endothelial Growth FactorsIBA
09/2017 - 05/2010
2Histones (Histone)IBA
01/2017 - 05/2015
2Protein Subunit VaccinesIBA
04/2016 - 09/2015
2Melphalan (Alkeran)FDA LinkGeneric
03/2016 - 08/2008
2Histone Deacetylases (Histone Deacetylase)IBA
01/2016 - 11/2006
2Transcription Factors (Transcription Factor)IBA
08/2015 - 05/2014
2RNA (Ribonucleic Acid)IBA
09/2014 - 01/2014
2liposomal doxorubicin (Doxil)FDA Link
06/2014 - 02/2013
2Nucleic AcidsIBA
01/2014 - 01/2014

Therapy/Procedure

29Therapeutics
01/2022 - 12/2004
15Drug Therapy (Chemotherapy)
11/2017 - 05/2010
9Immunotherapy
06/2022 - 04/2016
5Radiotherapy
01/2020 - 07/2006
4Aftercare (After-Treatment)
01/2022 - 12/2004
2Combination Drug Therapy (Combination Chemotherapy)
02/2013 - 06/2012